Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.
Title | Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., Ntenti C., Mandanas S., & Makras P. |
Journal | Endocrine |
Date Published | 2021 Mar 02 |
ISSN | 1559-0100 |
DOI | 10.1007/s12020-021-02666-5 |
Alternate Journal | Endocrine |
PubMed ID | 33651343 |